Skip to search formSkip to main contentSkip to account menu

travoprost 0.04 MG/ML Ophthalmic Solution [Travatan]

Known as: Travatan Z 0.004 % Ophthalmic Solution, TRAVOPROST 0.04 mg in 1 mL OPHTHALMIC SOLUTION [Travatan Z], TRAVOPROST 0.04 mg in 1 mL OPHTHALMIC SOLUTION/ DROPS [Travatan Z] 
National Institutes of Health

Related topics

Related topics

12 relations
Hydrochloric AcidOphthalmic SolutionPOLYOXYL 40 CASTOR OILPropylene glycol

Broader (1)

travoprost 0.04 MG/ML Ophthalmic Solution

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Changes of the Retina and Intrinsic Survival Signals in a Rat Model of Glaucoma following Brinzolamide and Travoprost Treatments
Purpose: The purpose of this study is to examine the changes of the retina and the intrinsic survival signals of the retina by… 
2008
2008
[Periocular hyperpigmentation following travoprost application].
2006
2006
PEY10 COST-EFFECTIVENESS OF TWO TREATMENT SEQUENCES IN GLAUCOMA TREATMENT: XALATAN®-XALACOM® VERSUS TRAVATAN®-DUOTRAV®
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)